MNCs Urge Indonesia For Exemption From Decree Requiring Local Manufacturing Facilities
This article was originally published in PharmAsia News
Executive Summary
Multinational companies are putting pressure on Indonesia's Ministry of Health to exempt them from a new decree requiring foreign drug companies to have local production facilities or leave Indonesia, according to Merck and Sanofi-Aventis
You may also be interested in...
Not Enough Beds To Go Around To Meet Asia’s Rising Demand For Medical Tourism
Frost & Sullivan weighs in on the state of medical tourism in southeast Asia, where some countries see greater opportunities for public-private partnerships.
Korean Government Fines Five Pharma Multinationals For Unfair Trade
SEOUL - South Korea's trade watchdog, the Fair Trade Commission, has imposed fines collectively totaling KRW 20.48 billion ($14.8 million) on seven pharmaceutical companies - including five multinationals - on charges of unfair provision of rebates and other improper benefits to doctors and hospitals
Korean Government Fines Five Pharma Multinationals For Unfair Trade
SEOUL - South Korea's trade watchdog, the Fair Trade Commission, has imposed fines collectively totaling KRW 20.48 billion ($14.8 million) on seven pharmaceutical companies - including five multinationals - on charges of unfair provision of rebates and other improper benefits to doctors and hospitals